EFSA Approves Iodine Claim for Infant Development
The agency agrees that iodine deficiency at an early age can lead to cognitive problems.
In response to a petition from the European trade association Specialised Nutrition Europe (Brussels), EFSA is approving a health claim for iodine and normal cognitive development in children 1 to 3 years of age.
EFSA’s approved claim will be applicable to all follow-on formula, nutritionally complete foods, and processed cereal foods that meet other existing criteria for the intended population of infants and young children. The health claim will read,"Iodine contributes to normal cognitive development."
Because a sufficient amount of evidence already exists in support of iodine for normal cognitive function in the general population-a previously approved health claim-EFSA’s decision to extend iodine’s nutritional standing to infants and children was not a difficult one. Specialised Nutrition Europe provided extra iodine science specific to young children, suggesting that iodine deficiency can, in some cases, lead to mental retardation and impaired growth.
Iodine is found in high amounts in sea vegetables, yogurt, milk, and strawberries. The established tolerable upper intake level for iodine in children, established previously, is 200 µg/day.
NPA files lawsuit against FDA for its decision on NMN
August 28th 2024The Natural Products Association (NPA; Washington, D.C.) has announced that they filed a lawsuit against the U.S. Food and Drug Administration (FDA) for its retroactive application of the Food, Drug, and Cosmetic Act (FD&C) against Nicotinamide Mononucleotide (NMN).
PLT Health Solution's Bosewellia serrata extract granted updated license by Health Canada
August 27th 2024The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.
